Diaper rash
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
topical barrier and good diaper practice
Good diapering hygiene practices should be ensured.[13]Nield LS, Kamat D. Prevention, diagnosis, and management of diaper dermatitis. Clin Pediatr (Phila). 2007 Jul;46(6):480-6. http://www.ncbi.nlm.nih.gov/pubmed/17579099?tool=bestpractice.com No matter which type of diaper is used, it should be changed every 2 hours (or inspected for soiling every 2 hours). Diapers should be changed even more frequently in newborns or in a child with diarrhea. Potential irritants at each diaper change should be eliminated by cleansing the diaper area with commercial cleansing wipes or water on cotton cloth. Products with minimal additives should be used, and excess friction and detergents should be avoided.
If the child is prone to frequent diaper rash, empirically apply a topical barrier containing zinc oxide, white soft paraffin, glycerin, lanolin, sucralfate, or mineral oil at each diaper change.[20]Sajjadian N, Hashemian F, Kadivar M, et al. Efficacy of topical sucralfate versus topical zinc oxide in diaper dermatitis: a randomized, double blind study. Iranian Journal of Dermatology. 2012;15(3):85-8. http://www.iranjd.ir/download.asp?code=IJD12156185 Zinc oxide is the preferred barrier for children with diarrhea. Topical preparations containing sucralfate as an active ingredient may need to be compounded by a pharmacist.
Allow for diaper-free time whenever practical. Avoid use of plastic underpants over diaper.
topical antifungal therapy
Topical antifungal creams can be used for rashes that persist beyond 3 days.
A topical barrier should be applied after the topical antimicrobial.
Primary options
nystatin topical: (100,000 units/g) apply to the affected area(s) three times daily, continue use for 3 days after rash clears
OR
miconazole topical: (0.25%) apply to the affected area(s) at each diaper change, continue for 7 days (even if rash has already cleared)
OR
econazole topical: (1%) apply to the affected area(s) twice daily, continue use for 3 days after rash clears
low-potency topical corticosteroids
Treatment recommended for SOME patients in selected patient group
Use if symptoms are severe, such as suspected pain and fussiness.
Use low potency, for 3 to 14 days only.[16]Šikić Pogačar M, Maver U, Marčun Varda N, et al. Diagnosis and management of diaper dermatitis in infants with emphasis on skin microbiota in the diaper area. Int J Dermatol. 2018 Mar;57(3):265-75. http://www.ncbi.nlm.nih.gov/pubmed/28986935?tool=bestpractice.com Misuse of topical corticosteroids in an occluded diaper may lead to increased systemic absorption, so should be used sparingly.
A topical barrier should be applied after treatment with a topical corticosteroid is completed, to avoid further skin damage.
Primary options
hydrocortisone topical: (1%) apply sparingly to the affected area(s) twice daily for 3-14 days
OR
desonide topical: (0.05%) apply sparingly to the affected area(s) twice daily for 3-14 days
topical antibacterial therapy
Treatment recommended for SOME patients in selected patient group
A topical antibacterial agent, such as mupirocin, should be applied if a secondary bacterial infection is suspected.[16]Šikić Pogačar M, Maver U, Marčun Varda N, et al. Diagnosis and management of diaper dermatitis in infants with emphasis on skin microbiota in the diaper area. Int J Dermatol. 2018 Mar;57(3):265-75. http://www.ncbi.nlm.nih.gov/pubmed/28986935?tool=bestpractice.com
Primary options
mupirocin topical: (2%) apply to the affected area(s) three times daily for up to 10 days
referral to a dermatologist
Recalcitrant cases should be referred to a dermatologist for possible biopsy or patch testing if they persist for >14 days.[13]Nield LS, Kamat D. Prevention, diagnosis, and management of diaper dermatitis. Clin Pediatr (Phila). 2007 Jul;46(6):480-6. http://www.ncbi.nlm.nih.gov/pubmed/17579099?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer